Del Zompo F, Crouchet E, Ostyn T, Nehme Z, Messé M, Juehling F, Désert R, Vieira AT, Moehlin J, Nakib D, Andrews T, Perciani C, Chung S, Bader G, McGilvray I, Caime C, Scaravaglio M, Carbone M, Invernizzi P, Yaqub S, Folseraas T, Karlsen TH, Shankar G, Primeaux M, Dhawan P et al. (2025)
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis
J Hepatol (in press)
DOI 10.1016/j.jhep.2025.08.005, PubMed 40846184

ElAbd H, Pesesky M, Innocenti G, Chung BK, Mahdy AKH, Kriukova V, Kulsvehagen L, Strobbe D, Stühler C, Mayr G, May DH, Prinzensteiner M, Steiert TA, Tran F, Hadjihannas MV, Günther R, Rosati E, Mucha S, Lieb W, Ziemann M, Dempfle A, Braun F, Folseraas T, Hov JR, Melum E et al. (2025)
T and B cell responses against Epstein-Barr virus in primary sclerosing cholangitis
Nat Med, 31 (7), 2306-2316
DOI 10.1038/s41591-025-03692-w, PubMed 40500415

Holmer M, Ingre M, Färkkilä M, Ponsioen C, Mol B, Schramm C, Folseraas T, Wiencke K, Cazzagon N, Catanzaro E, Molinaro A, Nilsson E, Vessby J, Kechagias S, Nyhlin N, Werner M, Bergquist A (2025)
Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study
Hepatology (in press)
DOI 10.1097/HEP.0000000000001351, PubMed 40238209